Respiratory Syncytial Virus — From Chimps with Colds to Conundrums and Cures
- 4 July 1991
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 325 (1) , 57-58
- https://doi.org/10.1056/nejm199107043250110
Abstract
Three and a half decades ago Morris et al.1 recovered from a chimpanzee with a cold a virus that had infected the entire colony and its handler. In subsequent years this contagious chimpanzee coryza agent earned a new name, respiratory syncytial virus. It is now recognized as the most important cause of lower respiratory tract disease in young children. Each year 95,000 children in the United States are hospitalized with lower respiratory tract disease due to respiratory syncytial virus, and more than 4500 die. Logarithmically greater numbers of children with respiratory syncytial virus infection are treated as outpatients. Recognition of . . .Keywords
This publication has 5 references indexed in Scilit:
- A Controlled Trial of Aerosolized Ribavirin in Infants Receiving Mechanical Ventilation for Severe Respiratory Syncytial Virus InfectionNew England Journal of Medicine, 1991
- Immunity to and Frequency of Reinfection with Respiratory Syncytial VirusThe Journal of Infectious Diseases, 1991
- Respiratory-Syncytial-Virus Infections, Reinfections and ImmunityNew England Journal of Medicine, 1979
- RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE12American Journal of Epidemiology, 1969
- Recovery of Cytopathogenic Agent from Chimpanzees with GoryzaExperimental Biology and Medicine, 1956